Actinium Therapy for Late-stage Aggressive Sarcomas
Actinium Therapy for Late-stage Aggressive Sarcomas
Recruiting · NCT07156565 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Actinium Therapy for Late-stage Aggressive Sarcomas | Disease Attributes, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm, sarcoma | Recruiting | Phase 1 | 2026-08-28 | NCT07156565 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ratio Therapeutics, Inc. | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Case Western | Cleveland | United States | 3 |
| Mayo Clinic | Rochester | United States | 664 |
| MD Anderson Cancer Center | Houston | United States | 2 |
| Memorial Sloane Kettering Cancer Center | New York | United States | 3 |
| Princess Margaret Cancer Centre | Toronto | Canada | 145 |
| UCLA | Los Angeles | United States | 80 |